US3122137A - Device for facilitating iontophoresis treatment of eyes - Google Patents
Device for facilitating iontophoresis treatment of eyes Download PDFInfo
- Publication number
- US3122137A US3122137A US148617A US14861761A US3122137A US 3122137 A US3122137 A US 3122137A US 148617 A US148617 A US 148617A US 14861761 A US14861761 A US 14861761A US 3122137 A US3122137 A US 3122137A
- Authority
- US
- United States
- Prior art keywords
- eye
- supporting means
- electrode
- contact
- holder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A61N1/303—Constructional details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H35/00—Baths for specific parts of the body
- A61H35/02—Baths for specific parts of the body for the eyes
Definitions
- This invention relates generally to apparatus for readily and safely utilizing iontophoresis in treating the human eye, and more particularly to apparatus enabling iontopho resis to be readily utilized by a patient to introduce medication into the eye without danger of injury to the eye.
- iontophoresis is the introduction of electrolytic drugs into living tissues under the driving power of a galvanic current. Ophthalmologists have long recognized the value of iontophoresis in the treatment of the eye. By the turn of the century various iontophoretic devices had been developed. With the advent of the miracle drugs, such as penicillin, the iontophoretic process came to be recognized as a highly effective way to administer these drugs.
- the concentration of penicillin, for example, introduced to the eye iontophoretically is ten times greater than that obtained by a bath application of equal duration. Not only does the iontophoretic process permit a more rapid medicine application, but it also permits a more localized and more highly concentrated application of drugs. Ophthalmologists also use iontophoresis in conjunction with the administration of drugs intramuscularly and intravenously to stimulate the eye, thereby causing a concentration of injected drugs in the eye and surrounding area.
- Epinephrine hydrochloride 1:1000 may be added to the foregoing solutions by using 1 to 2 drops.
- Streptomycin or neomycin 50-100 mg. per cc. (applied over the lids).
- (+) means introduction from the positive pole.
- () means introduction from the negative pole.
- An object of the invention is to provide an iontophoretic apparatus that can be used by the patient in accordance with a doctors directions but without a doctors aid.
- Another object of the invention is to provide an iontophoretic apparatus which is safe and does not place undue strain or pressure on the patients eye.
- Another object is to provide a self-administering iontophoretic apparatus which is inexpensively and simply constructed.
- Another object of the invention is to provide an eye-treating device using the iontophoretic principle and which is so constructed that the patients hands are left free while the treatment is being self-administered.
- Another object is to provide a unitary portable eye iontophoretic device which requires no conductors leading from an external energy source to the device.
- Another object of the invention is to provide means by which iontophoretic treatment of the eye and medicine application thereto can be accomplished with just the right amount of applicator pressure on the eye itself.
- Another object is to provide an eye iontophoretic device adapted to be principally supported by the area of the eye orbit around the eye and not the eye itself.
- FIGURE 1 is an exploded perspective view showing a supporting device together with a holder frame for holding the supporting device in operative position relative to the eye;
- FIGURE 2 is a fragmentary rear elevational view of the construction shown in FIGURE 1, part of a medicated pad being omitted;
- FIGURE 3 is a transverse sectional view taken on the line 33 of FIGURE 2, showing the supporting device supported by the eye orbit and a concave eye con tact area of the medicated pad touching the eye;
- FIGURE 4 is a cross sectional view of an alternative form of the invention.
- FIGURES l, 2 and 3 The embodiment of the invention shown in FIGURES l, 2 and 3 is adapted for use in connection with a holding structure, generally designated HS, formed quite like the frame of a pair of spectacles or eyeglasses.
- the device includes a supporting means 1 formed of any suitable nonconductive material such as plastic and which is annularly shaped with two separated adjacent generally cylindrical tubular portions 2 and 2 of different diameters.
- the smaller diameter portion 2 is shaped to provide an inner eye orbit receivable rim 3 adapted to lit the eye orbit of the patient.
- the outer part of the smaller diameter portion 2 is fast with a flat circular separator Wall 4 between the two portions 2 and 2'.
- the larger diameter portion 2' contains an electrical power source, e.g.
- the smaller diameter portion 2 of the supporting means 1 is backed with a metal electrode 8 which abuts the flat circular separator wall 4.
- a conductor 9 connects the electrode 8 with the battery 5 through the switch 7.
- a pad of medication-absorbent material 10 is positioned within the smaller diameter portion 2 so that it makes contact with the electrode 8.
- the absorbent material 10 is formed on its rear face into a concave eye contact area 11.
- the smaller diameter portion 2 is adjustably receivable by a holder frame 12 formed as part of the holder structure HS.
- a conductor 13 is provided between the battery 5 and a contact plate 14 located on the inner surface of the holder structure temple piece 15.
- FIGURES l, 2 and 3 The construction shown in FIGURES l, 2 and 3 is used by placing the holder structure HS on the head and hooking the temple pieces 15 into position over the ears.
- the contact plate 14 is then in electrically contacting relation with the head behind the eye area.
- the suppor ing means 1 is then inserted into the holder frame means 12 .and the pad it; is applied to the eye to be treated.
- the rim 3 of the supporting means abuts the eye orbit, thereby positioning the concave eye contact area 11 over and in light contact with the eye, and supporting the medication-administering device without applying undue strain on the eye itself.
- the iontophoretic process begins.
- Current from the battery passes through the medicated absorbent material 19, carrying some of the medicine in an ionized state into the eyeball and the surrounding area by the iontophoretic process.
- the medicine is deposited in the eyeball and surrounding area, and the electrical current passes harmlessly through the head tissue.
- a manually graspable, electrically conducting case 16 contains a battery 17 and is affixed to and carries a pad supporting means 18.
- the supporting means 18 is formed so that the inner rim 19 is shaped to fit the eye orbit of the patient.
- the supporting means 18 is internally backed with an electrode 29 and contains a medic ne-absorbent material which is formed at the rear into a concave eye contact area similar to that shown at 11 in FIGURE 3.
- the electrode 2% is connected to the battery 17 through a conductor 17' extending within an insulating stem 21, a spring 22 in a recess in the inner end of the stem 21, and a plunger 23 urged by the spring 22 into contact with the central battery terminal.
- An eye medication administering device comprising a holder structure substantially in the form of an'eyeglass frame, formed of a non-conductive material and having a holder frame and temple pieces; a contact plate positioned on one of the holder structure temple pieces so as to make contact with the rear portion of a patients head when the device is in use; a cylindrical supporting means adjustably mounted within the holder frame and composed of non-conductive material shaped to provide a rim which isengageable with and supportable by the eye orbit; a medication absorbent material disposed within the supporting means; an electrode carried by said supporting means and being situated so that the absorbent material is between and in contact with said electrode and the eye; and an electrical power source electrically connected to said electrode and said contact plate.
- An eye medication administering device comprising a holder frame structure substantially in the form of an eyeglass frame, formed of a non-conductive material and having a holder frame and temple pieces; a contact plate positioned on one of the holder structure temple pieces so as to make contact with the rear portion of a patients head when the device is in use; a cylindrical supporting means mounted within said holder frame means for adjustment normal to the eye and composed of non-conductive material shaped to provide a rim which is engageable with and supportable by the eye orbit; a medication absorbent material disposed within said supporting means and formed with an eye contact area positioned within said supporting means whereby the contact area makes contact with the eye when said supporting means rim is held against the eye orbit by said holder structure and the absorbent material bears substantially none of the weight of the device; an electrode carried by the supporting means and being situated so that the absorbent material is between and in contact with said electrode and the eye; and an electrical power source electrically connected to said electrode and said contact plate.
- An eye medication administering device comprising a holder frame structure substantially in the form of an eyeglass frame, formed of a non-conductive material and having a holder frame and temple pieces; a contact plate positioned on one of the holder structure temple pieces so as to make contact with the rear portion of a patients head when the device is in use; supporting means mounted within said holder frame for adjustment normal to the eye and being composed of non-conductive material shaped to provide a rim which is engageable with and supportable by the eye orbit;'a medication absorbent material disposed within said supporting means and formed with an eye contact area positioned within the supporting means whereby the contact area makes contact with the eye when said supporting means rim is held against the eye orbit by said holder structure, and the absorbent material bears substantially none of the weight of the device; an electrode carried by the supporting means and being situated so that the absorbent material is between and in contact with said electrode and the eye; and an electrical power source electrically connected to said I electrode and said contact plate.
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Electrotherapy Devices (AREA)
Description
Feb. 25, 1964 G, ERLANGLER 3,122,137
DEVICE FOR FACILITATING IONTOPHORESIS TREATMENT OF EYES Filed Oct. 30, 1961 INVENTOR. GUSTAV ERLANGER A TTORN E YS United States Patent 3,122,137 DEVICE FOR FACEITATING IONTOPHORESIS TREATMENT OF EYES Gustav Erlanger, 20 W. 77th St, New York 24, N.Y. Filed Oct. 30, 1961, Ser. No. 148,617 3 Claims. (Cl. 128-172.1)
This invention relates generally to apparatus for readily and safely utilizing iontophoresis in treating the human eye, and more particularly to apparatus enabling iontopho resis to be readily utilized by a patient to introduce medication into the eye without danger of injury to the eye.
As is now quite well known, iontophoresis is the introduction of electrolytic drugs into living tissues under the driving power of a galvanic current. Ophthalmologists have long recognized the value of iontophoresis in the treatment of the eye. By the turn of the century various iontophoretic devices had been developed. With the advent of the miracle drugs, such as penicillin, the iontophoretic process came to be recognized as a highly effective way to administer these drugs.
Experience has shown that the concentration of penicillin, for example, introduced to the eye iontophoretically is ten times greater than that obtained by a bath application of equal duration. Not only does the iontophoretic process permit a more rapid medicine application, but it also permits a more localized and more highly concentrated application of drugs. Ophthalmologists also use iontophoresis in conjunction with the administration of drugs intramuscularly and intravenously to stimulate the eye, thereby causing a concentration of injected drugs in the eye and surrounding area.
Some frequently used solutions for iontophoretic medication are:
Zinc sulfate l :500.
Calcium chloride 1.5 :500
Quinine hydrochloride 1: 1000.
Epinephrine hydrochloride 1:1000, may be added to the foregoing solutions by using 1 to 2 drops.
Histamine (Roche) 1: 10,000 to 1:20,000.
Acetylcholine chloride 1:400-1z2000.
Choline chloride 1:100.
Eserine salicylate 0.015 :500.
Methacholine chloride 0.25: 100.
Sodium para-aminosalicylate 1-2:100.
Sodium or calcium penicillin 500-2000 Oxford units per cc.
Gantrisin Roche 4%.
Aureomycin borate 1 mg. per cc.
Sodium sulfacetimide 110%.
Streptomycin or neomycin 50-100 mg. per cc. (applied over the lids).
(+) means introduction from the positive pole.
() means introduction from the negative pole.
Currently in use in the art of iontophoresis are pencillike electrodes which are held manually by a doctor to a patients eye, or devices which are attached to the eye itself, or are supported by the eye itself, and must be so attached or supported with extreme care by a doctor or experienced therapist.
An object of the invention is to provide an iontophoretic apparatus that can be used by the patient in accordance with a doctors directions but without a doctors aid.
Another object of the invention is to provide an iontophoretic apparatus which is safe and does not place undue strain or pressure on the patients eye.
Another object is to provide a self-administering iontophoretic apparatus which is inexpensively and simply constructed.
Another obiect of the invention, as embodied in one 3,122,137 Patented Feb. 25, 1964 form herein described, is to provide an eye-treating device using the iontophoretic principle and which is so constructed that the patients hands are left free while the treatment is being self-administered.
Another object is to provide a unitary portable eye iontophoretic device which requires no conductors leading from an external energy source to the device.
Another object of the invention is to provide means by which iontophoretic treatment of the eye and medicine application thereto can be accomplished with just the right amount of applicator pressure on the eye itself.
Another object is to provide an eye iontophoretic device adapted to be principally supported by the area of the eye orbit around the eye and not the eye itself.
Other objects will become apparent from a reading of the following description, the appended claims, and the accompanying drawings, in which:
FIGURE 1 is an exploded perspective view showing a supporting device together with a holder frame for holding the supporting device in operative position relative to the eye;
FIGURE 2 is a fragmentary rear elevational view of the construction shown in FIGURE 1, part of a medicated pad being omitted;
FIGURE 3 is a transverse sectional view taken on the line 33 of FIGURE 2, showing the supporting device supported by the eye orbit and a concave eye con tact area of the medicated pad touching the eye; and
FIGURE 4 is a cross sectional view of an alternative form of the invention.
The embodiment of the invention shown in FIGURES l, 2 and 3 is adapted for use in connection with a holding structure, generally designated HS, formed quite like the frame of a pair of spectacles or eyeglasses. As shown in these figures, the device includes a supporting means 1 formed of any suitable nonconductive material such as plastic and which is annularly shaped with two separated adjacent generally cylindrical tubular portions 2 and 2 of different diameters. The smaller diameter portion 2 is shaped to provide an inner eye orbit receivable rim 3 adapted to lit the eye orbit of the patient. The outer part of the smaller diameter portion 2 is fast with a flat circular separator Wall 4 between the two portions 2 and 2'. The larger diameter portion 2' contains an electrical power source, e.g. a galvanic battery 5, held in place by a clip 6 and provided with any suitable switch means 7. The smaller diameter portion 2 of the supporting means 1 is backed with a metal electrode 8 which abuts the flat circular separator wall 4. A conductor 9 connects the electrode 8 with the battery 5 through the switch 7. A pad of medication-absorbent material 10 is positioned within the smaller diameter portion 2 so that it makes contact with the electrode 8. The absorbent material 10 is formed on its rear face into a concave eye contact area 11.
As shown in FIGURE 1, the smaller diameter portion 2 is adjustably receivable by a holder frame 12 formed as part of the holder structure HS. A conductor 13 is provided between the battery 5 and a contact plate 14 located on the inner surface of the holder structure temple piece 15.
The construction of a single supporting device and its mounting on the holder structure HS have been described above. Two similar supporting devices may be mounted respectively in the two holder frame means 12, 12, de-
" pending upon whether one eye or both eyes is or are to be treated.
The construction shown in FIGURES l, 2 and 3 is used by placing the holder structure HS on the head and hooking the temple pieces 15 into position over the ears. The contact plate 14 is then in electrically contacting relation with the head behind the eye area. The suppor ing means 1 is then inserted into the holder frame means 12 .and the pad it; is applied to the eye to be treated. The rim 3 of the supporting means abuts the eye orbit, thereby positioning the concave eye contact area 11 over and in light contact with the eye, and supporting the medication-administering device without applying undue strain on the eye itself.
When the device is properly positioned and the current is turned on, the iontophoretic process begins. Current from the battery passes through the medicated absorbent material 19, carrying some of the medicine in an ionized state into the eyeball and the surrounding area by the iontophoretic process. The medicine is deposited in the eyeball and surrounding area, and the electrical current passes harmlessly through the head tissue.
In the alternative form of the invention as shown in FIGURE 4, a manually graspable, electrically conducting case 16 contains a battery 17 and is affixed to and carries a pad supporting means 18. The supporting means 18 is formed so that the inner rim 19 is shaped to fit the eye orbit of the patient. The supporting means 18 is internally backed with an electrode 29 and contains a medic ne-absorbent material which is formed at the rear into a concave eye contact area similar to that shown at 11 in FIGURE 3. The electrode 2% is connected to the battery 17 through a conductor 17' extending within an insulating stem 21, a spring 22 in a recess in the inner end of the stem 21, and a plunger 23 urged by the spring 22 into contact with the central battery terminal.
In using the construction shown in FIGURE 4, the case 16 is grasped by the patient and the rim 19 held against the orbital area with the medicated pad in contact with the eyeball, the patients eye orbit being subjected to the principal locating pressure, and the pad bearing on the eyeball with no more pressure than that required for producing effective electrical contact. Current will flow through the circuit provided by the battery 17, the
conductor 17', the electrode 20, the medicated pad, the I eyeball, and the patients body.
The constructions shown and described embody the in vention in preferred forms, but it is intended that the disclosure be illustrative rather than definitive, the invention being defined by the claims.
I claim:
1. An eye medication administering device comprising a holder structure substantially in the form of an'eyeglass frame, formed of a non-conductive material and having a holder frame and temple pieces; a contact plate positioned on one of the holder structure temple pieces so as to make contact with the rear portion of a patients head when the device is in use; a cylindrical supporting means adjustably mounted within the holder frame and composed of non-conductive material shaped to provide a rim which isengageable with and supportable by the eye orbit; a medication absorbent material disposed within the supporting means; an electrode carried by said supporting means and being situated so that the absorbent material is between and in contact with said electrode and the eye; and an electrical power source electrically connected to said electrode and said contact plate.
2. An eye medication administering device comprising a holder frame structure substantially in the form of an eyeglass frame, formed of a non-conductive material and having a holder frame and temple pieces; a contact plate positioned on one of the holder structure temple pieces so as to make contact with the rear portion of a patients head when the device is in use; a cylindrical supporting means mounted within said holder frame means for adjustment normal to the eye and composed of non-conductive material shaped to provide a rim which is engageable with and supportable by the eye orbit; a medication absorbent material disposed within said supporting means and formed with an eye contact area positioned within said supporting means whereby the contact area makes contact with the eye when said supporting means rim is held against the eye orbit by said holder structure and the absorbent material bears substantially none of the weight of the device; an electrode carried by the supporting means and being situated so that the absorbent material is between and in contact with said electrode and the eye; and an electrical power source electrically connected to said electrode and said contact plate.
3. An eye medication administering device comprising a holder frame structure substantially in the form of an eyeglass frame, formed of a non-conductive material and having a holder frame and temple pieces; a contact plate positioned on one of the holder structure temple pieces so as to make contact with the rear portion of a patients head when the device is in use; supporting means mounted within said holder frame for adjustment normal to the eye and being composed of non-conductive material shaped to provide a rim which is engageable with and supportable by the eye orbit;'a medication absorbent material disposed within said supporting means and formed with an eye contact area positioned within the supporting means whereby the contact area makes contact with the eye when said supporting means rim is held against the eye orbit by said holder structure, and the absorbent material bears substantially none of the weight of the device; an electrode carried by the supporting means and being situated so that the absorbent material is between and in contact with said electrode and the eye; and an electrical power source electrically connected to said I electrode and said contact plate.
References Cited in the file of this patent UNITED STATES PATENTS France June 2,
Claims (1)
1. AN EYE MEDICATION ADMINISTERING DEVICE COMPRISING A HOLDER STRUCTURE SUBSTANTIALLY IN THE FORM OF AN EYEGLASS FRAME, FORMED OF A NON-CONDUCTIVE MATERIAL AND HAVING A HOLDER FRAME AND TEMPLE PIECES; A CONTACT PLATE POSITIONED ON ONE OF THE HOLDER STRUCTURE TEMPLE PIECES SO AS TO MAKE CONTACT WITH THE REAR PORTION OF A PATIENT''S HEAD WHEN THE DEVICE IS IN USE; A CYLINDRICAL SUPPORTING MEANS ADJUSTABLY MOUNTED WITHIN THE HOLDER FRAME AND COMPOSED OF NON-CONDUCTIVE MATERIAL SHAPED TO PROVIDE A RIM WHICH IS ENGAGEABLE WITH AND SUPPORTABLE BY THE EYE ORBIT; A MEDICATION ABSORBENT MATERIAL DISPOSED WITHIN THE SUPPORTING MEANS; AN ELECTRODE CARRIED BY SAID SUPPORTING MEANS AND BEING SITUATED SO THAT THE ABSORBENT MATERIAL IS BETWEEN AND IN CONTACT WITH SAID ELECTRODE AND THE EYE, AND AN ELECTRICAL POWER SOURCE ELECTRICALLY CONNECTED TO SAID ELECTRODE AND SAID CONTACT PLATE.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US148617A US3122137A (en) | 1961-10-30 | 1961-10-30 | Device for facilitating iontophoresis treatment of eyes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US148617A US3122137A (en) | 1961-10-30 | 1961-10-30 | Device for facilitating iontophoresis treatment of eyes |
Publications (1)
Publication Number | Publication Date |
---|---|
US3122137A true US3122137A (en) | 1964-02-25 |
Family
ID=22526561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US148617A Expired - Lifetime US3122137A (en) | 1961-10-30 | 1961-10-30 | Device for facilitating iontophoresis treatment of eyes |
Country Status (1)
Country | Link |
---|---|
US (1) | US3122137A (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3376870A (en) * | 1965-03-08 | 1968-04-09 | Yamamoto Yujiro | Cranial electrode construction for sleep inducing machine |
US3464403A (en) * | 1964-07-25 | 1969-09-02 | Ceskoslovenska Akademie Ved | Sensing device for a plethysmograph |
US4018218A (en) * | 1975-03-12 | 1977-04-19 | Carlson James E | Method and apparatus for sleep induction |
US4100920A (en) * | 1975-09-02 | 1978-07-18 | Le Goaster Jacqueline Marie Ge | Method and apparatus for transferring microorganisms through the skin barrier |
FR2439592A1 (en) * | 1978-10-25 | 1980-05-23 | Jaffreo Albert | Mouth held device to excite salivary glands - utilises autonomous voltaic energy source mounted in rigid isolating mass and has covering of metallic alloy or amalgam |
US4319584A (en) * | 1980-05-19 | 1982-03-16 | Mccall Francis J | Electrical pulse acupressure system |
EP0060452A1 (en) * | 1981-03-05 | 1982-09-22 | Medtronic, Inc. | Iontophoretic device |
EP0084792A1 (en) * | 1982-01-11 | 1983-08-03 | Medtronic, Inc. | Non-invasive diagnosis method |
US4411648A (en) * | 1981-06-11 | 1983-10-25 | Board Of Regents, The University Of Texas System | Iontophoretic catheter device |
FR2548029A1 (en) * | 1983-06-30 | 1985-01-04 | Cusset Claude | Electronic medical apparatuses for treatment using trace elements |
US4635641A (en) * | 1985-10-16 | 1987-01-13 | Murray Electronics Associates Limited | Multi-element electrode |
WO1990007954A1 (en) * | 1989-01-17 | 1990-07-26 | University Of South Florida | Apparatus and methods for performing electrofusion |
US4955378A (en) * | 1988-05-02 | 1990-09-11 | University Of South Florida | Apparatus and methods for performing electrofusion at specific anatomical sites |
WO1997018855A1 (en) * | 1995-11-21 | 1997-05-29 | Eduard Naumovich Lerner | Device for enhanced delivery of biologically active substances and compounds in an organism |
US6154671A (en) * | 1998-01-05 | 2000-11-28 | Optisinvest | Device for the intraocular transfer of active products by iontophoresis |
US6319240B1 (en) * | 1999-05-25 | 2001-11-20 | Iomed, Inc. | Methods and apparatus for ocular iontophoresis |
US20020022794A1 (en) * | 1999-05-25 | 2002-02-21 | Beck Jon E. | Ocular iontophoretic apparatus handle |
US6539251B2 (en) | 1999-05-25 | 2003-03-25 | Iomed, Inc. | Ocular iontophoretic apparatus |
US6546283B1 (en) | 2000-10-18 | 2003-04-08 | Iomed, Inc. | High current density iontophoretic device and method of use thereof |
US6728573B1 (en) | 2000-02-23 | 2004-04-27 | Iomed, Inc. | Ocular iontophoretic apparatus handle |
WO2006072887A1 (en) | 2005-01-05 | 2006-07-13 | Eyegate Pharma Sa | Ocular iontophoresis device for delivering sirna and aptamers |
US20070123814A1 (en) * | 2005-11-29 | 2007-05-31 | Eyegate Pharmasa | Ocular iontophoresis device |
BE1016966A3 (en) * | 2006-01-26 | 2007-11-06 | El Khoury Juan R G | Interactive contact mask or spectacle for therapeutic treatment of eyes, has calibrated and interchangeable balls applied on eyes simultaneously or separately, where balls are maintained by traction and are transparent or opaque |
WO2012095876A1 (en) | 2011-01-12 | 2012-07-19 | Sooft Italia Spa | Device and method for corneal delivery of riboflavin by iontophoresis for the treatment of keratoconus |
CN106176190A (en) * | 2016-08-30 | 2016-12-07 | 宁波优视佳视力保健有限公司 | A kind of electric massage eye syringe |
CN106176191A (en) * | 2016-08-30 | 2016-12-07 | 宁波优视佳视力保健有限公司 | A kind of electronic eye syringe |
CN106236553A (en) * | 2016-08-30 | 2016-12-21 | 宁波优视佳视力保健有限公司 | Electric massage eye syringe |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US490678A (en) * | 1893-01-31 | Apparatus for electrically treating the eyes | ||
US551880A (en) * | 1895-12-24 | Theodore b | ||
FR398323A (en) * | 1909-01-07 | 1909-06-02 | Robert Wirtz | Ophthalmic electrodes for the local introduction of drugs by means of electric current, in case of eye diseases |
US999945A (en) * | 1910-07-19 | 1911-08-08 | Hermann Aub | Head-electrifying device. |
US2172573A (en) * | 1937-08-05 | 1939-09-12 | Isadore D Blumenthal | Eyeshield |
US2525381A (en) * | 1947-09-25 | 1950-10-10 | Tower Paul | Contact-type electrode holder |
US2834344A (en) * | 1954-07-22 | 1958-05-13 | Lion Brush K K | Device for penetrating teeth with fluoride |
-
1961
- 1961-10-30 US US148617A patent/US3122137A/en not_active Expired - Lifetime
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US490678A (en) * | 1893-01-31 | Apparatus for electrically treating the eyes | ||
US551880A (en) * | 1895-12-24 | Theodore b | ||
FR398323A (en) * | 1909-01-07 | 1909-06-02 | Robert Wirtz | Ophthalmic electrodes for the local introduction of drugs by means of electric current, in case of eye diseases |
US999945A (en) * | 1910-07-19 | 1911-08-08 | Hermann Aub | Head-electrifying device. |
US2172573A (en) * | 1937-08-05 | 1939-09-12 | Isadore D Blumenthal | Eyeshield |
US2525381A (en) * | 1947-09-25 | 1950-10-10 | Tower Paul | Contact-type electrode holder |
US2834344A (en) * | 1954-07-22 | 1958-05-13 | Lion Brush K K | Device for penetrating teeth with fluoride |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3464403A (en) * | 1964-07-25 | 1969-09-02 | Ceskoslovenska Akademie Ved | Sensing device for a plethysmograph |
US3376870A (en) * | 1965-03-08 | 1968-04-09 | Yamamoto Yujiro | Cranial electrode construction for sleep inducing machine |
US4018218A (en) * | 1975-03-12 | 1977-04-19 | Carlson James E | Method and apparatus for sleep induction |
US4100920A (en) * | 1975-09-02 | 1978-07-18 | Le Goaster Jacqueline Marie Ge | Method and apparatus for transferring microorganisms through the skin barrier |
FR2439592A1 (en) * | 1978-10-25 | 1980-05-23 | Jaffreo Albert | Mouth held device to excite salivary glands - utilises autonomous voltaic energy source mounted in rigid isolating mass and has covering of metallic alloy or amalgam |
US4319584A (en) * | 1980-05-19 | 1982-03-16 | Mccall Francis J | Electrical pulse acupressure system |
EP0060452A1 (en) * | 1981-03-05 | 1982-09-22 | Medtronic, Inc. | Iontophoretic device |
US4411648A (en) * | 1981-06-11 | 1983-10-25 | Board Of Regents, The University Of Texas System | Iontophoretic catheter device |
EP0084792A1 (en) * | 1982-01-11 | 1983-08-03 | Medtronic, Inc. | Non-invasive diagnosis method |
FR2548029A1 (en) * | 1983-06-30 | 1985-01-04 | Cusset Claude | Electronic medical apparatuses for treatment using trace elements |
US4635641A (en) * | 1985-10-16 | 1987-01-13 | Murray Electronics Associates Limited | Multi-element electrode |
US4955378A (en) * | 1988-05-02 | 1990-09-11 | University Of South Florida | Apparatus and methods for performing electrofusion at specific anatomical sites |
WO1990007954A1 (en) * | 1989-01-17 | 1990-07-26 | University Of South Florida | Apparatus and methods for performing electrofusion |
WO1997018855A1 (en) * | 1995-11-21 | 1997-05-29 | Eduard Naumovich Lerner | Device for enhanced delivery of biologically active substances and compounds in an organism |
US6154671A (en) * | 1998-01-05 | 2000-11-28 | Optisinvest | Device for the intraocular transfer of active products by iontophoresis |
US20020022794A1 (en) * | 1999-05-25 | 2002-02-21 | Beck Jon E. | Ocular iontophoretic apparatus handle |
US7252655B2 (en) | 1999-05-25 | 2007-08-07 | Iomed, Inc. | Ocular iontophoretic apparatus handle |
US6539251B2 (en) | 1999-05-25 | 2003-03-25 | Iomed, Inc. | Ocular iontophoretic apparatus |
US6319240B1 (en) * | 1999-05-25 | 2001-11-20 | Iomed, Inc. | Methods and apparatus for ocular iontophoresis |
US6728573B1 (en) | 2000-02-23 | 2004-04-27 | Iomed, Inc. | Ocular iontophoretic apparatus handle |
US6546283B1 (en) | 2000-10-18 | 2003-04-08 | Iomed, Inc. | High current density iontophoretic device and method of use thereof |
WO2006072887A1 (en) | 2005-01-05 | 2006-07-13 | Eyegate Pharma Sa | Ocular iontophoresis device for delivering sirna and aptamers |
US8099162B2 (en) | 2005-11-29 | 2012-01-17 | Eyegate Pharma, S.A.S. | Ocular iontophoresis device |
US20070123814A1 (en) * | 2005-11-29 | 2007-05-31 | Eyegate Pharmasa | Ocular iontophoresis device |
US9238131B2 (en) | 2005-11-29 | 2016-01-19 | Eyegate Pharma S.A.S. | Ocular iontophoresis device |
BE1016966A3 (en) * | 2006-01-26 | 2007-11-06 | El Khoury Juan R G | Interactive contact mask or spectacle for therapeutic treatment of eyes, has calibrated and interchangeable balls applied on eyes simultaneously or separately, where balls are maintained by traction and are transparent or opaque |
WO2012095876A1 (en) | 2011-01-12 | 2012-07-19 | Sooft Italia Spa | Device and method for corneal delivery of riboflavin by iontophoresis for the treatment of keratoconus |
US9700456B2 (en) | 2011-01-12 | 2017-07-11 | Sooft Italia Spa | Device and method for corneal delivery of riboflavin by iontophoresis for the treatment of keratoconus |
CN106176190A (en) * | 2016-08-30 | 2016-12-07 | 宁波优视佳视力保健有限公司 | A kind of electric massage eye syringe |
CN106176191A (en) * | 2016-08-30 | 2016-12-07 | 宁波优视佳视力保健有限公司 | A kind of electronic eye syringe |
CN106236553A (en) * | 2016-08-30 | 2016-12-21 | 宁波优视佳视力保健有限公司 | Electric massage eye syringe |
CN106236553B (en) * | 2016-08-30 | 2019-04-26 | 宁波优视佳视力保健有限公司 | Electric massage eye syringe |
CN106176190B (en) * | 2016-08-30 | 2019-05-03 | 宁波优视佳视力保健有限公司 | A kind of electric massage eye syringe |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3122137A (en) | Device for facilitating iontophoresis treatment of eyes | |
JP3405986B2 (en) | Device for treating inflammatory skin changes that are present at an early stage | |
US3991755A (en) | Iontophoresis apparatus for applying local anesthetics | |
US6101411A (en) | Dilation enhancer | |
KR101669715B1 (en) | Device and method for corneal delivery of riboflavin by iontophoresis for the treatment of keratoconus | |
US5174304A (en) | Electrocycloablation apparatus and method | |
US7346389B1 (en) | Dilation enhancer with pre-medicated contact lenses | |
US20060052834A1 (en) | Neurostimulation | |
GB2435217A (en) | Transcutaneous pain suppression device with multiple electrodes | |
JP2000510012A (en) | Drug delivery device by iontophoresis and method of using the same | |
DE69841028D1 (en) | Device for ocular iontophoresis for the administration of multiple drugs | |
US20130253412A1 (en) | Roller-ball applicator for transdermal iontophoretic delivery | |
KR102209529B1 (en) | Skin beauty apparatus | |
KR20100124118A (en) | Low frequency treatment device using cupping glass | |
GB2148717A (en) | Portable electro-acupuncture belt | |
CN1037408C (en) | Multifunctional therapeutic instrument for eye diseases | |
KR20000030485A (en) | The eye massager | |
GB2417688A (en) | Electrical transcutaneous pain suppression and pain location device | |
US407116A (en) | Electro-therapeutic device | |
JPH09103496A (en) | Iontophoresis device | |
RU2055568C1 (en) | Method for correction of erectable dysfunction and device for its embodiment | |
CN220159049U (en) | Electrotherapy instrument with anti-drop structure | |
CN2282899Y (en) | Interface circuit and electrode of ion-introduction instrument | |
ITBO990413A1 (en) | BI-REGENERATING BRACELET. | |
RU175231U1 (en) | DEVICE FOR IONOPHORESIS OF THE CORNE OF THE EYE |